In a report released yesterday, Andrew Harte from BTIG maintained a Hold rating on Global Payments (GPN – Research Report). The company’s ...
BTIG initiated coverage on ARMOUR Residential (NYSE:ARR) with a Neutral rating. The firm's analysis suggests a potential for ...
BTIG analyst Eric Hagen initiated coverage of Armour Residential REIT (ARR) with a Neutral rating and no price target The firm’s current ...
BTIG analysts maintained their Buy rating and $12.00 price target for SunCar Tech Group (NASDAQ:SDA), currently valued at $468 million. The firm's stance comes after the company's recent secondary ...
It fell 1.4 per cent in the US, McDonald's biggest market, its steepest drop since the COVID-19 pandemic almost five years ...
BTIG Research decreased their Q1 2025 earnings estimates for shares of Meritage Homes in a report issued on Tuesday, February ...
BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...
Am Mittwoch bekräftigten die Analysten von BTIG ihre positive Einschätzung zu GeneDx (NASDAQ:WGS) und wiederholten ihre Kaufempfehlung mit einem Kursziel von 95,00 US-Dollar. Dieses Ziel liegt ...
NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Am Donnerstag bekräftigten die Analysten von BTIG ihre Kaufempfehlung und ihr Kursziel von 15,00 US-Dollar für Coya Therapeutics (NASDAQ:COYA), nachdem neue klinische Studiendaten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback